cGMP-kinase mediates cGMP- and cAMP-induced Ca2+ desensitization of skinned rat artery

European Journal of Pharmacology

Volumn 323, Issue 1, 1997, Pages 75-82

  Kawada, Tomie ^a   Toyosato, Akira ^a   Islam, Md Omedul ^a   Yoshida, Yutaka ^a   Imai, Shoichi ^a  

^a NIIGATA UNIVERSITY   (Japan)

Author keywords

(Rp) 8 Bromo guanosine 3',5' cyclic monophosphorothioate; (Rp) Adenosine 3',5' cyclic monophosphorothioate; Ca2+ sensitivity; cAMP dependent protein kinase; cGMP dependent protein kinase; Smooth muscle, skinned, vascular

Indexed keywords

8 BROMO CYCLIC GMP; CALCIUM ION; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC GMP DEPENDENT PROTEIN KINASE; ISOENZYME;

ANIMAL TISSUE; AORTA; ARTICLE; COMPETITIVE INHIBITION; CONTROLLED STUDY; DESENSITIZATION; ENZYME KINETICS; MESENTERIC ARTERY; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR SMOOTH MUSCLE;

8-BROMO CYCLIC ADENOSINE MONOPHOSPHATE; ANALYSIS OF VARIANCE; ANIMALS; AORTA; CALCIUM; CATTLE; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYCLIC GMP; CYCLIC GMP-DEPENDENT PROTEIN KINASES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; HEART; ISOENZYMES; MALE; MESENTERIC ARTERIES; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; MYOCARDIUM; PHOSPHOLIPASE C; RATS; RATS, WISTAR; SWINE; THIONUCLEOTIDES;

EID: 0030960619     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)00028-9     Document Type: Article

References (36)

1. Butt, E., M. Van Bemmelen, L. Fischer, U. Walter and B. Jastorff, 1990, Inhibition of cGMP-dependent protein kinase by (Rp)-guanosine 3′,5′-monophosphorothiates, FEBS Lett. 263, 47.
2. Corbin, J.D. and T.M. Lincoln, 1978, Comparison of cAMP- and cGMP-dependent protein kinases, Adv. Cyclic Nucleotide Res. 9, 159.
3. 2+ by atriopeptin and 8-bromo-cyclic GMP is mediated by cyclic GMP-dependent kinase, J. Biol. Chem. 264, 1146.
4. Cornwell, T.D., K.B. Pryzwansky, T.A. Wyatt and T.M. Lincoln, 1991, Regulation of sarcoplasmic reticulum protein phosphorylation by localized cyclic GMP-dependent protein kinase in vascular smooth muscle cells, Mol. Pharmacol. 40, 923.
5. DeFeo, T.T. and K.G. Morgan, 1985, Calcium-force relationships as detected with aequorin in two different vascular smooth muscle of the ferret, J. Physiol. 369, 269.
6. De Wit, R.J.W., J. Hoppe, W.J. Stec, J. Baraniak and B. Jastorff, 1982, Interaction of cAMP derivatives with the 'stable' cAMP-binding site, in the cAMP-dependent protein kinase type I, Eur. J. Biochem. 122, 95.
7. De Wit, R.J.W., D. Hekstra, B. Jastorff, W.J. Stec, J. Baraniak, R. Van Driel and P.J.M. Van Haastert, 1984, Inhibitory action of certain cyclophosphate derivatives of cAMP on cAMP-dependent protein kinases, Eur. J. Biochem. 142, 255.
8. Francis, S.H., B.D. Noblett, B.W. Todd, J.N. Wells and J.D. Corbin, 1988, Relaxation of vascular and tracheal smooth muscle by cyclic nucleotide analogs that preferentially activate purified cGMP-dependent protein kinase, Mol. Pharmacol. 34, 506.
9. Gjersten, B.T., G. Mellgren, A. Otten, E. Maronde, H.-G. Genieser, B. Jastorff, O.K. Vintermyr, G.S. McKnight and S.O. Døskeland, 1995, Novel (Rp)-cAMPS analog as tools for inhibition of cAMP-kinase in cell culture, J. Biol. Chem. 270, 20599.
10. Hofmann, F., H.-P. Gensheimer, W. Landgraf, R. Hullin and B. Jastorff, 1985, Diastereomers of adenosine 3′,5′-monothionophosphate (cAMP[s]) antagonize the activation of cGMP-dependent protein kinase, Eur. J. Biochem. 150, 85.
11. Jiang, H., J.L. Colbran, S.H. Francis and J.D. Corbin, 1992, Direct evidence for cross-activation of cGMP-dependent protein kinase by cAMP in pig coronary arteries, J. Biol. Chem. 267, 1015.
12. Karaki, H., K. Sato, H. Ozaki and K. Murakami, 1988, Effects of sodium nitroprusside on cytosolic calcium level in vascular smooth muscle, Eur. J. Pharmacol. 156, 259.
13. 6-substituted derivatives of cyclic AMP as assessed in guinea-pig isolated right atria and papillary muscle, Br. J. Pharmacol. 97, 371.
14. Kawada, T., T. Ishibashi, H. Sasage, K. Kato and S. Imai, 1994, Modification by LY 83583 and methylene blue of relaxation induced by nitric oxide, glyceryl trinitrate, sodium nitroprusside and atriopeptin in aortae of the rat, guinea-pig and rabbit, Gen. Pharmacol. 25, 1361.
15. Komalavilas, P and T.M. Lincoln, 1996, Phosphorylation of the inositol 1,4,5-trisphosphate receptor: cyclic GMP-dependent protein kinase mediates cAMP and cGMP dependent phosphorylation in the intact rat aorta, J. Biol. Chem. 271, 21933.
16. Lincoln, T.M., 1983, cGMP-dependent protein kinase, Methods Enzymol. 99, 62.
17. Lincoln, T.M. and J.D. Corbin, 1983, Characterization and biological role of the cGMP-dependent protein kinase, Adv. Cyclic Nucleotide Res. 15, 139.
18. Lincoln, T.M. and T.L. Cornwell, 1991, Towards an understanding of the mechanism of action of cyclic AMP and cyclic GMP in smooth muscle relaxation, Blood Vessels 28, 129.
19. 2+ by cAMP in vascular smooth muscle cells, Am. J. Physiol. 258, C399.
20. i and uncoupling stress from myosin phosphorylation, Am. J. Physiol. 263, C461.
21. Murad, F., 1986, Cyclic guanosine monophosphate as a mediator of vasodilation, J. Clin. Invest. 78, 1.
22. Nakazawa, M. and S. Imai, 1994, Rp-8-Br-guanosine-3′,5′-cyclic monophosphorothioate inhibits relaxation elicited by nitroglycerin in rabbit aorta, Eur. J. Pharmacol. 253, 179.
23. Nishimura, J. and C. Van Breemen, 1989, Direct regulation of smooth muscle contractile elements by second messengers, Biochem. Biophys. Res. Commun. 163, 929.
24. Paterson, G.L., 1977, A simplification of the protein assay method of Lowry et al. which is more generally applicable, Anal. Biochem. 83, 346.
25. Pfizer, G. and P.J. Boels, 1991, Differential skinning of smooth muscle: a new approach to excitation-contraction coupling, Blood Vessels 28, 262.
26. Pfitzer, G., F. Hoffmann, J. DiSalvo and J.C. Rüegg, 1984, cGMP and cAMP inhibit tension development in skinned coronary arteries, Pflügers Arch. 401, 277.
27. Schults, K.D., K. Schultz and G. Schults, 1977, Sodium nitroprusside and other smooth muscle-relaxants increase cyclic GMP levels in rat ductus deference, Nature 265, 750.
28. Van Haastert, P.J.M., P.A.M. Dijkgraaf, T.M. Konijn, E.G. Abbad, G. Petridis and B. Jastorff, 1983, Substrate specificity of cyclic nucleotide phosphodiesterase from beef heart and from Dictyostelium discoideum, Eur. J. Biochem. 131, 659.
29. Van Haastert, P.J.M., R. Van Driel, B. Jastorff, J. Baraniak, W.J. Stec and R.J.W. De Wit, 1984, Competitive cAMP antagonists for cAMP-receptor proteins, J. Biol. Chem. 259, 10020.
30. Van Riper, D.A., B.A. Weaver, J.T. Stull and C.M. Rembold, 1995, Myosin light chain kinase phosphorylation in swine carotid artery contraction and relaxation, Am. J. Physiol. 268, H2466.
31. Van Rossum, J.M., 1963, Cumulative dose-response curves. II. Techniques for the making of dose-response curves in isolated organs and evaluation of drug parameters, Arch. Int. Pharmacodyn. Ther. 143, 299.
32. Waud, D.R. and R.B. Parker, 1971, Pharmacological estimation of drug-receptor dissociation constants. Statistical evolution. II. Competitive antagonists, J. Pharmacol. Exp. Ther. 177, 13.
33. Wolfe, L., J.D. Corbin and S.H. Francis, 1989, Characterization of a novel isozyme of cGMP-dependent protein kinase from bovine aorta, J. Biol. Chem. 264, 7734.
34. Wu, X., A.V. Somlyo and A.P. Somlyo, 1996, Cyclic GMP-dependent stimulation reverses G-protein-coupled inhibition of smooth muscle myosin light chain phosphatase, Biochem. Biophys. Res. Commun. 220, 658.
35. 2+ concentrations measured with fura-2, Br. J. Pharmacol. 98, 469.
36. Zimmerman, A.L., G. Yamanaka, F. Eckstein, D.A. Baylor and L. Stryer, 1985, Interaction of hydrolysis-resistant analogs of cyclic GMP with the phosphodiesterase and light-sensitive channel of retinal rod outer segments. Proc. Natl. Acad. Sci. USA 82, 8813.